These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 8937741

  • 1. Reduction of LAK-sensitivity and changes in antigen expression on hepatoma cells by sodium butyrate.
    Tada S, Saito H, Ebinuma H, Atsukawa K, Masuda T, Tsunematsu S, Morizane T, Ishii H.
    Cancer Biochem Biophys; 1996 Apr; 15(3):177-86. PubMed ID: 8937741
    [Abstract] [Full Text] [Related]

  • 2. Modulation of leukemic cell sensitivity to lymphokine-activated killer cytolysis: role of intercellular adhesion molecule-1.
    Triozzi PL, Eicher DM, Smoot J, Rinehart JJ.
    Exp Hematol; 1992 Oct; 20(9):1072-6. PubMed ID: 1361453
    [Abstract] [Full Text] [Related]

  • 3. Induction of intercellular adhesion molecule 1 on small cell lung carcinoma cell lines by gamma-interferon enhances spontaneous and bispecific anti-CD3 x antitumor antibody-directed lymphokine activated killer cell cytotoxicity.
    Azuma A, Yagita H, Matsuda H, Okumura K, Niitani H.
    Cancer Res; 1992 Sep 15; 52(18):4890-4. PubMed ID: 1381273
    [Abstract] [Full Text] [Related]

  • 4. Role of LFA-3, ICAM-1, and MHC class I on the sensitivity of human tumor cells to LAK cells.
    Gwin JL, Gercel-Taylor C, Taylor DD, Eisenberg B.
    J Surg Res; 1996 Jan 15; 60(1):129-36. PubMed ID: 8592403
    [Abstract] [Full Text] [Related]

  • 5. [LAK sensitivity of human pancreas carcinoma cell lines].
    Sugiura H.
    Hokkaido Igaku Zasshi; 1993 Nov 15; 68(6):921-34. PubMed ID: 7906667
    [Abstract] [Full Text] [Related]

  • 6. Expression and function of LFA-1 on A-NK and T-LAK cells: role in tumor target killing and migration into tumor tissue.
    Donskov F, Basse PH, Hokland M.
    Nat Immun; 1993 Nov 15; 15(2-3):134-46. PubMed ID: 9162263
    [Abstract] [Full Text] [Related]

  • 7. Membrane-associated lymphotoxin-expressing lymphokine-activated killer cells up-regulate intercellular adhesion molecule-1 expression on target tumor cells in vitro.
    Kimura K, Abe Y, Horiuchi A, Miyake M, Kimura S.
    Cell Immunol; 1995 Aug 15; 164(1):119-25. PubMed ID: 7634343
    [Abstract] [Full Text] [Related]

  • 8. Changes of antigen expression on human hepatoma cell lines caused by sodium butyrate, a differentiation inducer.
    Saito H, Tada S, Ebinuma H, Tsunematsu S, Kagawa T, Kumagai N, Inagaki Y, Watanabe T, Tsuchimoto K, Morizane T.
    J Gastroenterol; 1994 Dec 15; 29(6):733-9. PubMed ID: 7874268
    [Abstract] [Full Text] [Related]

  • 9. Effect of dexamethasone, dimethylsulfoxide and sodium butyrate on a human hepatoma cell line PLC/PRF/5.
    Saito H, Kagawa T, Tada S, Tsunematsu S, Guevara FM, Watanabe T, Morizane T, Tsuchiya M.
    Cancer Biochem Biophys; 1992 Nov 15; 13(2):75-84. PubMed ID: 1285320
    [Abstract] [Full Text] [Related]

  • 10. Different susceptibility of cervical keratinocytes containing human papillomavirus to cell-mediated cytotoxicity.
    Wu R, Coleman N, Stanley M.
    Chin Med J (Engl); 1996 Nov 15; 109(11):854-8. PubMed ID: 9275369
    [Abstract] [Full Text] [Related]

  • 11. Tumor growth suppression by a mouse/human chimeric anti-CEA antibody and lymphokine-activated killer cells in vitro and in SCID mouse xenograft model.
    Senba T, Kuroki M, Arakawa F, Yamamoto T, Kuwahara M, Haruno M, Ikeda S, Matsuoka Y.
    Anticancer Res; 1998 Nov 15; 18(1A):17-24. PubMed ID: 9568050
    [Abstract] [Full Text] [Related]

  • 12. Concomitant increases in galectin-1 and its glycoconjugate ligands (carcinoembryonic antigen, lamp-1, and lamp-2) in cultured human colon carcinoma cells by sodium butyrate.
    Ohannesian DW, Lotan D, Lotan R.
    Cancer Res; 1994 Nov 15; 54(22):5992-6000. PubMed ID: 7954433
    [Abstract] [Full Text] [Related]

  • 13. Properties of target molecule of murine lymphokine-activated killer (LAK) cells and the clones.
    Hashimoto Y, Kato K, Sato N, Yagi H, Yagita H, Nishimura T.
    Princess Takamatsu Symp; 1988 Nov 15; 19():315-22. PubMed ID: 3077625
    [Abstract] [Full Text] [Related]

  • 14. CD80 transfected human hepatocellular carcinoma cells activate cytotoxic T lymphocytes to target HCC cells with shared tumor antigens.
    Chan RC, Xie Y.
    Oncol Rep; 2004 Aug 15; 12(2):435-42. PubMed ID: 15254713
    [Abstract] [Full Text] [Related]

  • 15. Loss of butyrate-induced apoptosis in human hepatoma cell lines HCC-M and HCC-T having substantial Bcl-2 expression.
    Saito H, Ebinuma H, Takahashi M, Kaneko F, Wakabayashi K, Nakamura M, Ishii H.
    Hepatology; 1998 May 15; 27(5):1233-40. PubMed ID: 9581676
    [Abstract] [Full Text] [Related]

  • 16. The role of N-linked carbohydrate residues in lymphokine-activated killer cell-mediated cytolysis.
    Mehta BA, Collard HR, Negrin RS.
    Cell Immunol; 1994 Apr 15; 155(1):95-110. PubMed ID: 7909499
    [Abstract] [Full Text] [Related]

  • 17. Enhancement of lymphokine-activated killer cell induction using anti-CD25 and anti-CTLA-4 monoclonal antibodies.
    Okita R, Yamaguchi Y, Emi A, Matsuura K, Toge T.
    Oncol Rep; 2007 Jun 15; 17(6):1429-35. PubMed ID: 17487401
    [Abstract] [Full Text] [Related]

  • 18. A lymphokine-activated killer (LAK)-resistant cell line, and low expression of adhesion molecules LFA-3 and VCAM-1 on its cell surface.
    Komatsu F, Kajiwara M.
    Oncol Res; 1998 Jun 15; 10(5):263-9. PubMed ID: 9802061
    [Abstract] [Full Text] [Related]

  • 19. Role of beta1 integrins in adhesion and invasion of hepatocellular carcinoma cells.
    Masumoto A, Arao S, Otsuki M.
    Hepatology; 1999 Jan 15; 29(1):68-74. PubMed ID: 9862852
    [Abstract] [Full Text] [Related]

  • 20. Cancer cell cycle and adoptive immunotherapy using lymphokine-activated killer cells.
    Ejiri Y, Ohara M, Suzuki T, Kasukawa R.
    Fukushima J Med Sci; 1997 Dec 15; 43(2):61-73. PubMed ID: 9640842
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.